Sarah Taylor Anderson - Feb 20, 2025 Form 4 Insider Report for SelectQuote, Inc. (SLQT)

Role
Executive Vice President, Healthcare
Signature
/s/ Daniel A. Boulware, Attorney-in-Fact
Stock symbol
SLQT
Transactions as of
Feb 20, 2025
Transactions value $
-$272,000
Form type
4
Date filed
2/26/2025, 05:07 PM
Previous filing
Oct 30, 2024
Next filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLQT Common Stock, par value $0.01 per share Options Exercise $28.1K +15K +41.48% $1.88 51.2K Feb 20, 2025 Direct
transaction SLQT Common Stock, par value $0.01 per share Sale -$272K -50K -97.72% $5.44 1.17K Feb 20, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLQT Employee Stock Options Options Exercise -$28.1K -15K -88.24% $1.88 2K Feb 20, 2025 Common Stock, par value $0.01 per share 15K $1.88 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Amount reported represents a weighted average price. On February 20, 2025, Ms. Anderson sold 50,000 shares in multiple transactions at prices ranging from $5.37 to $5.74, inclusive. The reporting person undertakes to provide to SelectQuote, Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
F2 Represents incentive stock options of the Company granted to the recipient pursuant to the Company's 2003 Stock Incentive Plan. Each option represents the contingent right to purchase one share of the Company's common stock, par value $0.01 per share, at a predetermined price specified in Column 8 of this table.
F3 The option vests ratably in three annual installments commencing on the one-year anniversary of the grant date, February 8, 2018, subject to the recipient's continued employment with the Company through the applicable vesting date.

Remarks:

Executive Vice President, Healthcare